In my last post, I talked about Ampyra, an oral drug that was recently approved by the FDA to treat MS. This drug does nothing to treat the Multiple Sclerosis disease process itself, rather, it is meant to increase muscle strength and mobility, and provide some symptom relief for MS sufferers. In trials, Ampyra helped 35% of subjects taking it increase their walking speed by 25% (in timed 25 foot walks).
New imaging approach promises insights into multiple sclerosis
synapse
Tuesday, April 17, 2007 - 00:42
[img_assist|nid=126|title=Myelin sheath and astroglial filaments|desc=|link=popup|align=right|width=100|height=216]
WEST LAFAYETTE, Ind. -
Researchers have developed a way to use three types of microscopic imaging techniques simultaneously to analyze living tissue and learn more about the molecular mechanisms of multiple sclerosis, information that could help lead to earlier detection and new treatments.
